Xiaoye Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoye Liu has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Kui Zhu
State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
6 shared publications - Hong Dong
Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, Beijing, China
5 shared publications Wenjing Zhang
Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, No.7 Beinong Road, Changping, Beijing, China
4 shared publicationsZhigang Sun
College of Veterinary Medicine, Beijing University of Agriculture, No.7 Beinong Road, Changping, Beijing, China
4 shared publicationsJing Wang
Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, No.7 Beinong Road, Changping, Beijing, China
3 shared publications- Shuangyang Ding
Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, PR China
3 shared publications
Latest Publications
- 20 July 2026
- Published by Elsevier in Phytomedicine
- Vol. 159, 158621
Quercetin as tigecycline adjuvant reverses multidrug-resistant Acinetobacter baumannii infection
- 20 July 2026
- Published by Elsevier in Phytomedicine
- Vol. 159, 158621
Quercetin as tigecycline adjuvant reverses multidrug-resistant Acinetobacter baumannii infection
- Open Access
- 14 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1538
Genomic Characterization of Multidrug-Resistant Escherichia coli from Bovine Mastitis and Therapeutic Evaluation of Thanatin Combined with Gallium Nitrate
Bovine mastitis caused by multidrug-resistant (MDR) Escherichia coli remains a major challenge in the dairy industry due to recurrent infection, excessive lipopolysaccharide (LPS) release, and persistent mammary inflammation. Whole-genome sequencing (WGS) revealed that the clinical isolate was resistant to seven classes of antibiotics and exhibited a marked enrichment of iron uptake systems, which accounted for 27.14% of the 140 virulence genes identified. Upon this, we developed a targeted combination therapy using the iron mimetic gallium nitrate and the antimicrobial peptide thanatin (Tn). A rat model of mastitis was established to evaluate the in vivo therapeutic efficacy of the Tn-gallium nitrate combination. Our results demonstrated that the combination of gallium nitrate and Tn exerted a potent enhanced therapeutic effect in the rat mastitis model. This regimen significantly inhibited bacterial proliferation, neutralized endotoxin activity, and downregulated the expression of pro-inflammatory cytokines. Histopathological evaluation confirmed that the combination therapy effectively protected the alveolar structure and alleviated tissue damage, with a protective effect superior to that of ceftiofur (CEF), the first-line clinical drug. Collectively, our findings demonstrate the therapeutic potential of the combination of thanatin and gallium nitrate in a rat model of mastitis and provide experimental evidence supporting the development of a novel non-antibiotic therapeutic strategy for bovine mastitis caused by multidrug-resistant E. coli.
- 14 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1538
Open AccessGenomic Characterization of Multidrug-Resistant Escherichia coli from Bovine Mastitis and Therapeutic Evaluation of Thanatin Combined with Gallium Nitrate
Bovine mastitis caused by multidrug-resistant (MDR) Escherichia coli remains a major challenge in the dairy industry due to recurrent infection, excessive lipopolysaccharide (LPS) release, and persistent mammary inflammation. Whole-genome sequencing (WGS) revealed that the clinical isolate was resistant to seven classes of antibiotics and exhibited a marked enrichment of iron uptake systems, which accounted for 27.14% of the 140 virulence genes identified. Upon this, we developed a targeted combination therapy using the iron mimetic gallium nitrate and the antimicrobial peptide thanatin (Tn). A rat model of mastitis was established to evaluate the in vivo therapeutic efficacy of the Tn-gallium nitrate combination. Our results demonstrated that the combination of gallium nitrate and Tn exerted a potent enhanced therapeutic effect in the rat mastitis model. This regimen significantly inhibited bacterial proliferation, neutralized endotoxin activity, and downregulated the expression of pro-inflammatory cytokines. Histopathological evaluation confirmed that the combination therapy effectively protected the alveolar structure and alleviated tissue damage, with a protective effect superior to that of ceftiofur (CEF), the first-line clinical drug. Collectively, our findings demonstrate the therapeutic potential of the combination of thanatin and gallium nitrate in a rat model of mastitis and provide experimental evidence supporting the development of a novel non-antibiotic therapeutic strategy for bovine mastitis caused by multidrug-resistant E. coli.
- 21 August 2025
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 66 (6) , 107595
Flavonols interrupt internalized bacteria hijacking cellular responses via suppressing oxidative stress induced cellular apoptotic death
- 21 August 2025
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 66 (6) , 107595
Flavonols interrupt internalized bacteria hijacking cellular responses via suppressing oxidative stress induced cellular apoptotic death
- Open Access
- 23 June 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (7) , 611
Synergistic Efficacy of Doxycycline and Florfenicol Against Aeromonas hydrophilia and Morganella morganii Infections in Pelodiscus sinensis with Skin Ulcer Disease
The intensive farming of Pelodiscus sinensis (P. sinensis) for its medicinal and economic value has led to an increased incidence of bacterial skin infections, commonly treated with antibiotics. However, rising antibiotic resistance has reduced the effectiveness of these treatments, highlighting an urgent need for alternative therapeutic approaches. In this study, we isolated and identified pathogenic bacteria (Aeromonas and Morganella) from P. sinensis affected by skin ulcer disease at a turtle farm in Beijing. Antibiotic resistance was evaluated using the checkerboard microdilution method and the in vitro antibacterial efficacy of a florfenicol–doxycycline combination therapy was assessed. A total of 30 bacterial isolates were obtained, primarily Morganella and Aeromonas species. Among these, 83.3% of Morganella and 57.14% of Aeromonas isolates demonstrated multidrug-resistance. The florfenicol–doxycycline combination yielded lower fractional inhibitory concentration (FIC) values, indicating synergistic or additive effects. Animal experiments have shown that florfenicol in combination with doxycycline can achieve better therapeutic effects with less drug. These findings support that combination antibiotic therapies help in managing skin ulcer disease in P. sinensis and offer valuable insights for clinical applications.
- 23 June 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (7) , 611
Open AccessSynergistic Efficacy of Doxycycline and Florfenicol Against Aeromonas hydrophilia and Morganella morganii Infections in Pelodiscus sinensis with Skin Ulcer Disease
The intensive farming of Pelodiscus sinensis (P. sinensis) for its medicinal and economic value has led to an increased incidence of bacterial skin infections, commonly treated with antibiotics. However, rising antibiotic resistance has reduced the effectiveness of these treatments, highlighting an urgent need for alternative therapeutic approaches. In this study, we isolated and identified pathogenic bacteria (Aeromonas and Morganella) from P. sinensis affected by skin ulcer disease at a turtle farm in Beijing. Antibiotic resistance was evaluated using the checkerboard microdilution method and the in vitro antibacterial efficacy of a florfenicol–doxycycline combination therapy was assessed. A total of 30 bacterial isolates were obtained, primarily Morganella and Aeromonas species. Among these, 83.3% of Morganella and 57.14% of Aeromonas isolates demonstrated multidrug-resistance. The florfenicol–doxycycline combination yielded lower fractional inhibitory concentration (FIC) values, indicating synergistic or additive effects. Animal experiments have shown that florfenicol in combination with doxycycline can achieve better therapeutic effects with less drug. These findings support that combination antibiotic therapies help in managing skin ulcer disease in P. sinensis and offer valuable insights for clinical applications.
- Open Access
- 2 June 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-15
Natural flavonoids combat cytosolic MRSA by potentiating phagosome acidification
The emergence of multidrug-resistant bacteria (MDR), particularly in cytosolic methicillin-resistant Staphylococcus aureus (MRSA) are causing substantial infections and posing an urgent global threat to public health. The era of antibiotic resistant has hindered the development of antibiotics that solely target bacteria, highlighting the need for alternative therapeutic strategies. Host-acting therapies are emerging as a dominant approach to address the shortage of novel antibiotics and prevent novel-resistant bacteria. Herein, we explored the modes of action of five flavonoids that combat cytosolic MRSA through host-acting antibacterial effects. Both in vitro and in vivo models demonstrated the efficacy of flavonoids in combating cytosolic MRSA lung infections. Transcriptomic and proteomic analyses revealed that the antibacterial targets of these flavonoids are linked to the phagosome pathway. Mechanistic studies further showed that flavonoids enhance lysosomal acidification, identifying it as a viable target for host-acting antibacterial drugs. These findings suggest that flavonoid treatments represent a promising host-acting therapeutic strategy for combating cytosolic MRSA infections.
- 2 June 2025
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-15
Open AccessNatural flavonoids combat cytosolic MRSA by potentiating phagosome acidification
The emergence of multidrug-resistant bacteria (MDR), particularly in cytosolic methicillin-resistant Staphylococcus aureus (MRSA) are causing substantial infections and posing an urgent global threat to public health. The era of antibiotic resistant has hindered the development of antibiotics that solely target bacteria, highlighting the need for alternative therapeutic strategies. Host-acting therapies are emerging as a dominant approach to address the shortage of novel antibiotics and prevent novel-resistant bacteria. Herein, we explored the modes of action of five flavonoids that combat cytosolic MRSA through host-acting antibacterial effects. Both in vitro and in vivo models demonstrated the efficacy of flavonoids in combating cytosolic MRSA lung infections. Transcriptomic and proteomic analyses revealed that the antibacterial targets of these flavonoids are linked to the phagosome pathway. Mechanistic studies further showed that flavonoids enhance lysosomal acidification, identifying it as a viable target for host-acting antibacterial drugs. These findings suggest that flavonoid treatments represent a promising host-acting therapeutic strategy for combating cytosolic MRSA infections.
- Open Access
- 19 March 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (3) , e0216024
Current prevalence and therapeutic strategies for porcine Streptococcus suis in China
Porcine Streptococcus suis is a zoonotic bacterial pathogen that poses serious threats to both human and animal health. S. suis is ubiquitously transmitted from the swine industry to the environments and human communities. However, the ambiguous epidemiological patterns and the escalating risk of antimicrobial resistance render S. suis infections a considerable challenge. Here, we review the current prevalence of S. suis infection worldwide, including identified bacterial strains, routes of infection, and transformation of resistance genes. This comprehensive overview of the prevalent patterns in S. suis offers detailed insights into therapeutic approaches for porcine infections and alternative strategies to address emerging resistant strains, highlighting potential multitarget prevention and treatment options to combat S. suis infection.
- 19 March 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (3) , e0216024
Open AccessCurrent prevalence and therapeutic strategies for porcine Streptococcus suis in China
Porcine Streptococcus suis is a zoonotic bacterial pathogen that poses serious threats to both human and animal health. S. suis is ubiquitously transmitted from the swine industry to the environments and human communities. However, the ambiguous epidemiological patterns and the escalating risk of antimicrobial resistance render S. suis infections a considerable challenge. Here, we review the current prevalence of S. suis infection worldwide, including identified bacterial strains, routes of infection, and transformation of resistance genes. This comprehensive overview of the prevalent patterns in S. suis offers detailed insights into therapeutic approaches for porcine infections and alternative strategies to address emerging resistant strains, highlighting potential multitarget prevention and treatment options to combat S. suis infection.
- Open Access
Communications between Neutrophil–Endothelial Interaction in Immune Defense against Bacterial Infection
The endothelial barrier plays a critical role in immune defense against bacterial infection. Efficient interactions between neutrophils and endothelial cells facilitate the activation of both cell types. However, neutrophil activation can have dual effects, promoting bacterial clearance on one hand while triggering inflammation on the other. In this review, we provide a detailed overview of the cellular defense progression when neutrophils encounter bacteria, focusing specifically on neutrophil–endothelial interactions and endothelial activation or dysfunction. By elucidating the underlying mechanisms of inflammatory pathways, potential therapeutic targets for inflammation caused by endothelial dysfunction may be identified. Overall, our comprehensive understanding of neutrophil–endothelial interactions in modulating innate immunity provides deeper insights into therapeutic strategies for infectious diseases and further promotes the development of antibacterial and anti-inflammatory drugs.
Open AccessCommunications between Neutrophil–Endothelial Interaction in Immune Defense against Bacterial Infection
The endothelial barrier plays a critical role in immune defense against bacterial infection. Efficient interactions between neutrophils and endothelial cells facilitate the activation of both cell types. However, neutrophil activation can have dual effects, promoting bacterial clearance on one hand while triggering inflammation on the other. In this review, we provide a detailed overview of the cellular defense progression when neutrophils encounter bacteria, focusing specifically on neutrophil–endothelial interactions and endothelial activation or dysfunction. By elucidating the underlying mechanisms of inflammatory pathways, potential therapeutic targets for inflammation caused by endothelial dysfunction may be identified. Overall, our comprehensive understanding of neutrophil–endothelial interactions in modulating innate immunity provides deeper insights into therapeutic strategies for infectious diseases and further promotes the development of antibacterial and anti-inflammatory drugs.
- Open Access
- 27 September 2023
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 10, 1288837
Corrigendum: Dregs of Cardamine hupingshanensis as a feed additive to improve the egg quality
Corrigendum: Dregs of Cardamine hupingshanensis as a feed additive to improve the egg quality
- 27 September 2023
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 10, 1288837
Open AccessCorrigendum: Dregs of Cardamine hupingshanensis as a feed additive to improve the egg quality
Corrigendum: Dregs of Cardamine hupingshanensis as a feed additive to improve the egg quality
- Open Access
- 28 July 2022
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 915865
Dregs of Cardamine hupingshanensis as a feed additive to improve the egg quality
Natural plant herbs have many active compounds to prevent poultry diseases and improve poultry products. However, most herbs are supplied for human medicine. Thus, for economic and sustainable development purposes, the dregs of Cardamine hupingshanensis (DCH) were developed as a feed additive to improve the egg quality of laying hens in this work. Results showed that the contents of selenium in hen serum and eggs were increased under DCH feeding. Subsequently, DCH also promotes the antioxidant capacity and immunity of laying hens through the increase of superoxide dismutase (SOD), catalase (CAT), and immunoglobulin G (IgG) by ELISA detection. Finally, production performance and egg quality were further graded by monitoring the product condition and scoring the indexes of egg quality, which also displayed that DCH as a feed additive significantly improved the egg quality by enhancing yolk color, eggshell thickness, and egg shape index.
- 28 July 2022
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 915865
Open AccessDregs of Cardamine hupingshanensis as a feed additive to improve the egg quality
Natural plant herbs have many active compounds to prevent poultry diseases and improve poultry products. However, most herbs are supplied for human medicine. Thus, for economic and sustainable development purposes, the dregs of Cardamine hupingshanensis (DCH) were developed as a feed additive to improve the egg quality of laying hens in this work. Results showed that the contents of selenium in hen serum and eggs were increased under DCH feeding. Subsequently, DCH also promotes the antioxidant capacity and immunity of laying hens through the increase of superoxide dismutase (SOD), catalase (CAT), and immunoglobulin G (IgG) by ELISA detection. Finally, production performance and egg quality were further graded by monitoring the product condition and scoring the indexes of egg quality, which also displayed that DCH as a feed additive significantly improved the egg quality by enhancing yolk color, eggshell thickness, and egg shape index.
- Open Access
- 27 June 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 873374
Antibacterial Modes of Herbal Flavonoids Combat Resistant Bacteria
The increasing dissemination of multidrug resistant (MDR) bacterial infections endangers global public health. How to develop effective antibacterial agents against resistant bacteria is becoming one of the most urgent demands to solve the drug resistance crisis. Traditional Chinese medicine (TCM) with multi-target antibacterial actions are emerging as an effective way to combat the antibacterial resistance. Based on the innovative concept of organic wholeness and syndrome differentiation, TCM use in antibacterial therapies is encouraging. Herein, advances on flavonoid compounds of heat-clearing Chinese medicine exhibit their potential for the therapy of resistant bacteria. In this review, we focus on the antibacterial modes of herbal flavonoids. Additionally, we overview the targets of flavonoid compounds and divide them into direct-acting antibacterial compounds (DACs) and host-acting antibacterial compounds (HACs) based on their modes of action. We also discuss the associated functional groups of flavonoid compounds and highlight recent pharmacological activities against diverse resistant bacteria to provide the candidate drugs for the clinical infection.
- 27 June 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 873374
Open AccessAntibacterial Modes of Herbal Flavonoids Combat Resistant Bacteria
The increasing dissemination of multidrug resistant (MDR) bacterial infections endangers global public health. How to develop effective antibacterial agents against resistant bacteria is becoming one of the most urgent demands to solve the drug resistance crisis. Traditional Chinese medicine (TCM) with multi-target antibacterial actions are emerging as an effective way to combat the antibacterial resistance. Based on the innovative concept of organic wholeness and syndrome differentiation, TCM use in antibacterial therapies is encouraging. Herein, advances on flavonoid compounds of heat-clearing Chinese medicine exhibit their potential for the therapy of resistant bacteria. In this review, we focus on the antibacterial modes of herbal flavonoids. Additionally, we overview the targets of flavonoid compounds and divide them into direct-acting antibacterial compounds (DACs) and host-acting antibacterial compounds (HACs) based on their modes of action. We also discuss the associated functional groups of flavonoid compounds and highlight recent pharmacological activities against diverse resistant bacteria to provide the candidate drugs for the clinical infection.